What is Juvenile-Onset Primary Sclerosing Cholangitis?
Juvenile-Onset Primary Sclerosing Cholangitis (PSC) is a chronic liver disease that affects children and adolescents. It involves inflammation and scarring of the bile ducts, which carry bile from the liver to the small intestine. Over time, this damage leads to blockages, bile buildup, liver damage, and potentially liver failure.
PSC is rare in children but can be serious. It is often linked to autoimmune conditions, especially inflammatory bowel disease (IBD), such as ulcerative colitis.
What causes it?
The exact cause of PSC is unknown, but it is believed to be autoimmune-related, where the immune system attacks the body’s own bile ducts. Possible contributing factors include:
- Genetics – it may run in families
- Immune system dysfunction
- Associated conditions, especially ulcerative colitis or Crohn’s disease
- Environmental triggers
It is not caused by alcohol or infections, and it is not contagious.
What are the symptoms?
Symptoms can develop slowly and may be mild at first. Common signs and symptoms include:
- Fatigue
- Itching (pruritus)
- Jaundice (yellowing of the skin and eyes)
- Abdominal pain, especially in the right upper side
- Dark urine and pale stools
- Fever and chills (if an infection develops)
- Unintended weight loss
In some cases, children may have no symptoms, and PSC is discovered during blood tests for another condition.
How is it diagnosed?
Diagnosis involves a combination of tests to evaluate liver function and visualize the bile ducts:
- Blood tests to check liver enzymes and markers of inflammation
- Magnetic Resonance Cholangiopancreatography (MRCP) – a special MRI to look at the bile ducts
- Liver biopsy to assess liver inflammation and fibrosis
- Endoscopic Retrograde Cholangiopancreatography (ERCP) – occasionally used to view and treat the bile ducts
- Autoimmune markers if an autoimmune cause is suspected
- Stool and imaging tests if associated IBD is present
How is it treated?
There is currently no cure for PSC, but treatments can help manage symptoms and complications:
- Medications to relieve itching and improve bile flow
- Antibiotics for bile duct infections
- Ursodeoxycholic acid (UDCA) – may help in some patients to improve liver function
- Treatment for IBD if present
- Endoscopic procedures to open narrowed bile ducts
- Liver transplant – may be necessary if liver failure or severe complications develop
Regular follow-ups are essential to monitor liver health and catch complications early.
What are the possible complications?
- Liver cirrhosis and failure
- Portal hypertension (high pressure in liver blood vessels)
- Recurrent cholangitis (bile duct infections)
- Cholangiocarcinoma (bile duct cancer) – rare but serious
- Gallbladder issues or cancer
- Osteoporosis or poor bone growth in children due to liver dysfunction
Monitoring and managing these risks is a key part of care.
What is the prognosis?
The course of Juvenile-Onset PSC varies:
- Some children remain stable for many years with few symptoms
- Others may develop liver complications early and require transplant
- Children with both PSC and IBD may face more challenges but can still lead active lives with proper treatment
Early diagnosis, good medical care, and regular monitoring improve long-term outcomes.
When should I see a doctor?
Consult a healthcare provider if a child experiences:
- Persistent fatigue or itching
- Yellowing of the skin or eyes
- Abdominal pain or swelling
- Abnormal liver test results
- Family history of liver disease or IBD